Insider trade

Officer sold ~$167K of UTHR shares in the open market

Traded Aug 6, 2026 · Filed Aug 7, 2026

Why it stands out

United Therapeutics's & GENERAL COUNSEL sold $167K of United Therapeutics shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Officer$100K–$500KPre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$167,166

Shares × reported transaction price

Timing vs results

1 day after results of Aug 5, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025.

5w ago

Derivative exercise or conversion — not an open-market buy.

5w ago

Derivative exercise or conversion — not an open-market buy.

Scheduled in advance5w ago